GlassScriptPhysician profile
David Michael Campsey
NPI 1467417048
$20,637.14
in general payments reported to CMS, 2019-2025
31 companies · $5,435 in 2025
The $5,435 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,103 · 2020: $1,508 · 2021: $2,132 · 2022: $3,710 · 2023: $2,068 · 2024: $3,681 · 2025: $5,435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,401 · Travel and Lodging: $3,753 · Education: $29.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,400.65 |
| Travel and Lodging | $3,753.37 |
| Education | $29.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,432.87 | 2021-2025 | Symplicity G3, Onyx Frontier, Linq II |
| Abbott Laboratories | $3,265.06 | 2019-2025 | Amplatzer Amulet, Thoratec Heartmate 3 Lvas Implant Kit, Aveir |
| Boston Scientific Corporation | $1,975.88 | 2019-2025 | Avvigo Guidance System, Watchman Access System, Rotablator Rotational Atherectomy System Console Kit |
| Medtronic Vascular, INC. | $1,763.29 | 2019-2020 | |
| Abiomed | $1,663.53 | 2019-2024 | Impella |
| Edwards Lifesciences Corporation | $1,442.69 | 2020-2025 | Sapien 3 Ultra Resilia |
| Bard Peripheral Vascular, INC. | $1,188.40 | 2024 | Venclose Maven Catheter |
| Inari Medical, INC. | $388.32 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $331.55 | 2022-2025 | Lifevest |
| Stryker Corporation | $298.68 | 2025 | Clottriever Bold Catheter, Artix Mt, Flowtriever Catheter, S |
| Penumbra, INC. | $231.31 | 2025 | Indigo System |
| Heartflow, INC. | $201.80 | 2023-2025 | Ffrct |
| Tactile Systems Technology INC | $172.42 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Actelion Pharmaceuticals US, INC. | $168.10 | 2019-2022 | |
| Cerus Corporation | $160.12 | 2023-2024 | Intercept Blood System For Platelets |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $146.31 | 2025 | Torus Stent Graft System, Endocross Device |
| Impulse Dynamics (USA) INC. | $137.83 | 2022 | |
| Surmodics, INC. | $108.58 | 2022-2025 | Pounce Thrombectomy System, Pounce Xl Thrombectomy, Pounce Venous Thrombectomy System |
| Shockwave Medical, INC | $96.60 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $85.25 | 2019-2023 | Xarelto |
| Cardiovascular Systems INC. | $80.39 | 2021 | |
| Angiodynamics, INC. | $66.94 | 2025 | Angiovac |
| Biotronik INC. | $53.33 | 2019-2022 | |
| Amgen INC. | $42.41 | 2019 | |
| Philips North America LLC | $31.03 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $25.66 | 2022-2023 | Brilinta |
| W. L. Gore & Associates, INC. | $18.68 | 2024 | Gore Cardioform Septal Occluder |
| Cvrx, INC. | $16.29 | 2023 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.82 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $14.64 | 2023 | Camzyos |
| Pfizer INC. | $14.36 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Campsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.